AU688735B2 - Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists - Google Patents

Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists Download PDF

Info

Publication number
AU688735B2
AU688735B2 AU47903/93A AU4790393A AU688735B2 AU 688735 B2 AU688735 B2 AU 688735B2 AU 47903/93 A AU47903/93 A AU 47903/93A AU 4790393 A AU4790393 A AU 4790393A AU 688735 B2 AU688735 B2 AU 688735B2
Authority
AU
Australia
Prior art keywords
alkyl
group
document
phenyl
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU47903/93A
Other languages
English (en)
Other versions
AU4790393A (en
Inventor
Robert John Ardecky
Carol Lee Ensinger
James Russell Pruitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Publication of AU4790393A publication Critical patent/AU4790393A/en
Application granted granted Critical
Publication of AU688735B2 publication Critical patent/AU688735B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU47903/93A 1992-08-06 1993-08-02 Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists Ceased AU688735B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/926,795 US5310929A (en) 1992-08-06 1992-08-06 Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
US926795 1992-08-06
PCT/US1993/007103 WO1994003435A1 (en) 1992-08-06 1993-08-02 Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists

Publications (2)

Publication Number Publication Date
AU4790393A AU4790393A (en) 1994-03-03
AU688735B2 true AU688735B2 (en) 1998-03-19

Family

ID=25453732

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47903/93A Ceased AU688735B2 (en) 1992-08-06 1993-08-02 Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists

Country Status (18)

Country Link
US (1) US5310929A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0654027A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2892838B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1090275A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU688735B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9306911A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2141692C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI950485L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU9500349D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL106553A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9304787A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO950404D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL307309A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG47108A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK13195A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW239131B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1994003435A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA935693B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
RU2109736C1 (ru) * 1992-12-17 1998-04-27 Санкио Компани Лимитед Производные бифенила и способ их получения
EP1110551B1 (en) * 1994-03-16 2004-05-12 Sankyo Company Limited Ocular tension lowering agent
US6221335B1 (en) * 1994-03-25 2001-04-24 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US5510495A (en) * 1994-09-19 1996-04-23 The Du Pont Merck Pharmaceutical Company Process for the isolation and purification of ester functionalized imidazole intermediates by selective hydrolysis
WO1996009301A1 (fr) * 1994-09-20 1996-03-28 Wakunaga Seiyaku Kabushiki Kaisha Procede de production d'un derive de n-biphenylmethylthiadiazoline ou un sel de celui-ci et son intermediaire de production
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
IT1295405B1 (it) 1997-09-30 1999-05-12 Merck Sharp & Dohme Italia S P Uso di un antagonista recettoriale di angiotensina ii per la preparazione di farmaci per aumentare il tasso di sopravvivenza di
DE19820064A1 (de) * 1998-05-06 1999-11-11 Hoechst Marion Roussel De Gmbh Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
DE19832428A1 (de) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19832429A1 (de) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
ES2154191B1 (es) * 1998-11-24 2001-10-16 Ferrer Int Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos.
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
MXPA03011693A (es) 2001-05-31 2004-12-06 Vicore Pharma Ab Compuestos triciclicos utiles como agonistas de la angiotensina ii.
WO2004065383A2 (en) * 2003-01-16 2004-08-05 Teva Pharmaceutical Industries Ltd. Novel synthesis of irbesartan
CN1910284B (zh) 2004-01-20 2011-04-06 爱知县 由HLA-A2402-限制的Ep-CAM-特异的CTL识别的表位/肽及其应用
US7157584B2 (en) * 2004-02-25 2007-01-02 Takeda Pharmaceutical Company Limited Benzimidazole derivative and use thereof
KR100953878B1 (ko) * 2004-09-02 2010-04-22 테바 파마슈티컬 인더스트리즈 리미티드 올메살탄 메독소밀의 정제
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
WO2006115834A1 (en) * 2005-04-20 2006-11-02 Merck & Co., Inc. Angiotensin ii receptor antagonists
EP1931648A2 (en) * 2006-08-29 2008-06-18 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of 5-phenyl -1 trityl-1h-tetrazole
CA2663981C (en) * 2006-10-09 2014-05-27 Cipla Limited Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil
EP2103610B1 (en) * 2006-12-06 2011-09-21 Shanghai Allist Pharmaceutical., Inc. Salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof
EP2521545B1 (en) 2010-01-07 2019-11-27 Alkermes Pharma Ireland Limited Prodrugs of heteroaromatic compounds
EP2455388A1 (en) 2010-11-23 2012-05-23 LanthioPep B.V. Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
CN109320501B (zh) * 2013-11-01 2021-06-01 深圳信立泰药业股份有限公司 阿利沙坦酯无定形及其制备方法及含所述无定形的药物组合物
US20220257698A1 (en) 2019-08-02 2022-08-18 Lanthiopep B.V. Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2777189A (en) * 1988-01-07 1989-07-13 E.I. Du Pont De Nemours And Company Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
WO1992000977A2 (en) * 1990-07-13 1992-01-23 E.I. Du Pont De Nemours And Company 4-alkylimidazole derivatives
AU3988093A (en) * 1992-06-02 1993-12-09 Sankyo Company Limited Angiotensin ii antagonist imidazole derivatives, their preparation and their therapeutic use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
FI916129A7 (fi) * 1989-06-30 1991-12-27 Du Pont Substituoituja imidatsoleja
CA2059000C (en) * 1989-06-30 1998-01-20 Robert John Ardecky Fused-ring aryl substituted imidazoles
GB8927277D0 (en) * 1989-12-01 1990-01-31 Glaxo Group Ltd Chemical compounds
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2777189A (en) * 1988-01-07 1989-07-13 E.I. Du Pont De Nemours And Company Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
WO1992000977A2 (en) * 1990-07-13 1992-01-23 E.I. Du Pont De Nemours And Company 4-alkylimidazole derivatives
AU3988093A (en) * 1992-06-02 1993-12-09 Sankyo Company Limited Angiotensin ii antagonist imidazole derivatives, their preparation and their therapeutic use

Also Published As

Publication number Publication date
IL106553A0 (en) 1993-12-08
FI950485A0 (fi) 1995-02-03
FI950485A7 (fi) 1995-02-03
PL307309A1 (en) 1995-05-15
BR9306911A (pt) 1998-12-08
TW239131B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-01-21
NO950404D0 (no) 1995-02-03
US5310929A (en) 1994-05-10
CA2141692C (en) 2006-05-30
MX9304787A (es) 1995-01-31
AU4790393A (en) 1994-03-03
ZA935693B (en) 1995-02-06
JPH08500103A (ja) 1996-01-09
SG47108A1 (en) 1998-03-20
WO1994003435A1 (en) 1994-02-17
EP0654027A1 (en) 1995-05-24
FI950485L (fi) 1995-02-03
JP2892838B2 (ja) 1999-05-17
HU9500349D0 (en) 1995-03-28
CN1090275A (zh) 1994-08-03
SK13195A3 (en) 1995-07-11
CA2141692A1 (en) 1994-02-17

Similar Documents

Publication Publication Date Title
AU688735B2 (en) Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
US5512681A (en) Angiotensin II receptor blocking imidazolinone derivatives
CA2036304C (en) Pyrimidinedione derivatives, their production and use
EP0497150B1 (en) Angiotensin II receptor blocking 2,3,6-substituted quinazolones
PL183931B1 (pl) Nowe związki, pochodne imidazolu i kompozycje farmaceutyczne je zawierające
SK281941B6 (sk) Deriváty kyseliny indol-2-karboxylovej, ich použitie, spôsob ich prípravy a farmaceutický prípravok s ich obsahom
GB2268743A (en) Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
WO1992007834A1 (en) N-substituted imidazol-2-one compounds for treatment of circulatory disorders
MX2013003364A (es) Inhibidores de metaloproteinasa de matriz.
HK1046909A1 (en) Piperazine derivatives as 5-ht1b antagonists
CS9100906A2 (en) Substituted azoles, method of their production, preparations that contain these compounds and their application
LU85442A1 (fr) Agents antidepression a base de 1,2,4-triazol-3-one
JP2013505220A (ja) Ｐ２ｘ７調節薬としての縮合トリアゾールアミン類
ES2273617T3 (es) Compuestos de feniltetrazol.
KR0162637B1 (ko) 단백질 키나아제 c 억제제로서 유용한 신규 퀴놀릴옥사졸-2-온
WO2003006670A2 (en) 2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
CA2072775A1 (en) Substituted triazolinones
JPH0390062A (ja) 置換ｎ―（キノリン―２―イル―メトキシ）ベンジルスルホニルウレア
US5294617A (en) Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
US4472422A (en) Antihypertensive 4,5-diaryl-α-polyfluoro-alkyl-1H-imidazole-2-methanamines
JP2001515893A (ja) 特定のベンゾチアジンジオキシドエンドセリンアンタゴニスト類およびその製造方法
JPH0789957A (ja) ビフェニルメチルアミン誘導体
US5288720A (en) Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
WO2006134078A1 (en) Method for obtaining benzimidazole derivatives and intermediates thereof
EP1282619A1 (en) Processes for the preparation of thiazolidinedione derivatives and intermediates

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired